Maria Ada Eufemia Forss
Director Ejecutivo en BICO GROUP AB .
Fortuna: 168 948 $ al 30/04/2024
Perfil
Maria Ada Eufemia Forss is currently the President & Chief Executive Officer at BICO Group AB.
She is also a Director at Mabtech AB.
Previously, she held positions such as Chief Executive Officer at DuoCort Pharma AB, Chairman at Bico International AB, Deputy Director at Laccure AB, Director at Oncorena AB and Oncorena Holding AB, and Independent Director at LIDDS AB.
From 2012 to 2023, she worked as the VP-Business Development & Global Communications at Vitrolife AB.
She also served as the Head-Business Development at Aqilion AB and as a Principal at AstraZeneca A.
Ms. Forss completed her undergraduate and MBA degrees at Concordia University.
She also has a graduate degree from Handelshögskolan i Göteborg.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
BICO GROUP AB CLASS B
0.06% | 23/05/2024 | 40 051 ( 0.06% ) | 168 948 $ | 30/04/2024 |
Cargos activos de Maria Ada Eufemia Forss
| Empresas | Cargo | Inicio |
|---|---|---|
| BICO GROUP AB | Director Ejecutivo | 20/11/2023 |
Mabtech AB
 Mabtech AB Miscellaneous Commercial ServicesCommercial Services Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de Maria Ada Eufemia Forss.
| Empresas | Cargo | Fin |
|---|---|---|
| VITROLIFE AB | Public Communications Contact | - |
| Bico International AB | Presidente | - |
Oncorena AB
 Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Director/Miembro de la Junta | - |
Aqilion AB
 Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Corporate Officer/Principal | - |
| LIDDS AB | Director/Miembro de la Junta | - |
Formación de Maria Ada Eufemia Forss.
| Concordia University | Masters Business Admin |
| Handelshögskolan i Göteborg | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| VITROLIFE AB | Health Technology |
| LIDDS AB | Health Technology |
| BICO GROUP AB | Health Technology |
| Empresas privadas | 8 |
|---|---|
Aqilion AB
Aqilion AB Investment ManagersFinance Aqilion AB is a venture capital firm. The firm was founded in 2002 by Jan Ekberg and Mats G. Ringesten. It's headquartered in Helsingborg, Sweden. | Finance |
AstraZeneca A/S /Denmark/
 AstraZeneca A/S /Denmark/ Pharmaceuticals: MajorHealth Technology AstraZeneca A/S sells and distributes pharmaceutical products to the health sector. It specializes within therapy areas of the gastrointestinal diseases, respiratory diseases, cardiovascular diseases, neuroscience, and oncology. The company was founded in 1943 and is headquartered in Copenhagen, Denmark. | Health Technology |
Laccure AB
 Laccure AB Pharmaceuticals: GenericHealth Technology Laccure AB develops products for the treatment and prevention of bacterial vaginosis. It is a pharmaceutical company that offers non-prescription vaginal tablet for women. The firm's product is based on a proprietary substance that releases lactic acid over an extended period of time to decrease elevated vaginal potential of hydrogen. It engages in research, development, training, marketing, and sales in the field of skin care and hygiene activities. The company was founded by Olov Arvid Sterner in 2007 and is headquartered in Helsingborg, Sweden. | Health Technology |
DuoCort Pharma AB
 DuoCort Pharma AB Pharmaceuticals: MajorHealth Technology DuoCort Pharma AB conducts research, development, training, marketing, and sales in the medical field. The firm operates drug development company focused on improving glucocorticoid therapy. It develops Plenadren, a once daily dual-release hydrocortisone replacement therapy for patients with chronic adrenal insufficiency. The company was founded on July 6, 2007 and is headquartered in Stockholm, Sweden. | Health Technology |
Oncorena AB
Oncorena AB Pharmaceuticals: MajorHealth Technology Oncorena AB develops a novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies in humans. The company was founded in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
Mabtech AB
Mabtech AB Miscellaneous Commercial ServicesCommercial Services Mabtech AB manufactures immunological and biotechnological products. It produces a wide range of monoclonal antibodies to cytokines, immunoglobulins, and apolipoproteins for applications in life science research. The firm's products Elisa, Elispot, and Fluorospot Kits; antibodies; and supplementary products. The company was founded by Staffan Paulie, Kjell Olov Östrand, and Sten Braesch-Andersen in 1986 and is headquartered in Nacka Strand, Sweden. | Commercial Services |
Oncorena Holding AB
 Oncorena Holding AB Pharmaceuticals: MajorHealth Technology Oncorena Holding AB develops novel pharmacological treatment for metastatic renal clear cell cancer. It conducts clinical trial for potential new therapies. The company was founded by Björn Oskar Larsson in 2011 and is headquartered in Helsingborg, Sweden. | Health Technology |
| Bico International AB |
- Bolsa de valores
- Insiders
- Maria Ada Eufemia Forss
